X-30834146-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_152787.5(TAB3):c.1895C>T(p.Ser632Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000174 in 1,206,395 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000054 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000014 ( 0 hom. 3 hem. )
Consequence
TAB3
NM_152787.5 missense
NM_152787.5 missense
Scores
1
5
11
Clinical Significance
Conservation
PhyloP100: 4.94
Genes affected
TAB3 (HGNC:30681): (TGF-beta activated kinase 1 (MAP3K7) binding protein 3) The product of this gene functions in the NF-kappaB signal transduction pathway. The encoded protein, and the similar and functionally redundant protein MAP3K7IP2/TAB2, forms a ternary complex with the protein kinase MAP3K7/TAK1 and either TRAF2 or TRAF6 in response to stimulation with the pro-inflammatory cytokines TNF or IL-1. Subsequent MAP3K7/TAK1 kinase activity triggers a signaling cascade leading to activation of the NF-kappaB transcription factor. The human genome contains a related pseudogene. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.21790537).
BS2
High Hemizygotes in GnomAdExome4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TAB3 | NM_152787.5 | c.1895C>T | p.Ser632Leu | missense_variant | 10/11 | ENST00000288422.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TAB3 | ENST00000288422.4 | c.1895C>T | p.Ser632Leu | missense_variant | 10/11 | 5 | NM_152787.5 | P1 | |
TAB3 | ENST00000378930.7 | c.1895C>T | p.Ser632Leu | missense_variant | 6/7 | 1 | P1 | ||
TAB3 | ENST00000378933.5 | c.1895C>T | p.Ser632Leu | missense_variant | 11/12 | 1 | P1 | ||
TAB3 | ENST00000378932.6 | c.1811C>T | p.Ser604Leu | missense_variant | 10/11 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000537 AC: 6AN: 111701Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33885
GnomAD3 genomes
AF:
AC:
6
AN:
111701
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33885
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000329 AC: 6AN: 182111Hom.: 0 AF XY: 0.0000300 AC XY: 2AN XY: 66621
GnomAD3 exomes
AF:
AC:
6
AN:
182111
Hom.:
AF XY:
AC XY:
2
AN XY:
66621
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000137 AC: 15AN: 1094694Hom.: 0 Cov.: 29 AF XY: 0.00000833 AC XY: 3AN XY: 360096
GnomAD4 exome
AF:
AC:
15
AN:
1094694
Hom.:
Cov.:
29
AF XY:
AC XY:
3
AN XY:
360096
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000537 AC: 6AN: 111701Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33885
GnomAD4 genome
AF:
AC:
6
AN:
111701
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33885
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.1895C>T (p.S632L) alteration is located in exon 10 (coding exon 6) of the TAB3 gene. This alteration results from a C to T substitution at nucleotide position 1895, causing the serine (S) at amino acid position 632 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Uncertain
D;D;T
Polyphen
B;B;B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at